Cannabics Pharmaceuticals Building a Diversified Portfolio of CDB-Based Products
Cannabics Pharmaceuticals (OTCQB: CNBX), an early-stage Biotechnology Company focussed on creating cannabinoid-based therapeutics and therapies for treatment of cancer, announced the signing of a Memorandum of Understanding (MoU) with RCK Medical Cannabis, an Israeli cannabis company that creates tailor-made medical cannabis strains and hybrid seeds...
